While several studies found deregulation of Sirt1 in various tumor entitites including ovary, prostate, gastric, colon, hepatocellular carcinoma as well as melanoma and glioblastoma [27], comprehensive in vivo data in pancreatic cancer is still missing. Here, SIRT1 is linked to neoplasm.